Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions BPC 157: Experimental Peptide Creates Risk for Athletes BPC 157 Peptide Erectile Dysfunction: Exploring the Research and Real World Use Is BPC 157 Legal? Understanding Its Status and Implications